Clinical trial
Pharmacokinetic Study Of EPZICOM Tablet
NCT00337922 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00337922 |
|---|---|
| Title | Pharmacokinetic Study Of EPZICOM Tablet |
| Official title | Post-Marketing Clinical Study of EPZICOM Tablet (Lamivudine / Abacavir Sulfate) - Pharmacokinetic Study in HIV-Infected Patients - |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | Lamivudine / Abacavir Sulfate |
| Enrollment | 8 |
| Start date | Jul 1, 2006 |
| First posted | Jun 20, 2006 |
| Last update posted | Oct 16, 2008 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: